View Past PerformanceRobertet バランスシートの健全性財務の健全性 基準チェック /56Robertetの総株主資本は€602.5M 、総負債は€225.3Mで、負債比率は37.4%となります。総資産と総負債はそれぞれ€1.0Bと€399.5Mです。 Robertetの EBIT は€143.9Mで、利息カバレッジ比率40です。現金および短期投資は€180.7Mです。主要情報37.40%負債資本比率€225.32m負債インタレスト・カバレッジ・レシオ40x現金€180.67mエクイティ€602.50m負債合計€399.53m総資産€1.00b財務の健全性に関する最新情報更新なしすべての更新を表示Recent updatesDeclared Dividend • May 21Dividend increased to €12.00Dividend of €12.00 is 20% higher than last year. Ex-date: 29th June 2026 Payment date: 1st July 2026 Dividend yield will be 1.5%, which is lower than the industry average of 6.1%. Sustainability & Growth Dividend is well covered by both earnings (25% earnings payout ratio) and cash flows (40% cash payout ratio). The dividend has increased by an average of 12% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. EPS is expected to grow by 24% over the next 3 years, which should provide support to the dividend and adequate earnings cover.Board Change • May 21Less than half of directors are independentFollowing the recent departure of a director, there are only 5 independent directors on the board. The company's board is composed of: 5 independent directors. 6 non-independent directors. Independent Director Guy Talbourdet was the last independent director to join the board, commencing their role in 2025. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.お知らせ • Apr 28Robertet SA, Annual General Meeting, Jun 03, 2026Robertet SA, Annual General Meeting, Jun 03, 2026. Location: 48 avenue jean maubert, grasse Franceお知らせ • Apr 11Robertet SA Proposes Dividend for the Year 2025Robertet SA announced the Annual General Meeting will be held on June 3, 2026 and the shareholders will be invited to approve a dividend payment of €12 per share, up 20% on the previous year owing to Robertet's strong results in 2025.お知らせ • Feb 12Robertet SA to Report First Half, 2026 Final Results on Sep 21, 2026Robertet SA announced that they will report first half, 2026 final results on Sep 21, 2026お知らせ • Jan 02+ 2 more updatesRobertet SA to Report Fiscal Year 2025 Results on Apr 09, 2026Robertet SA announced that they will report fiscal year 2025 results at 9:00 AM, Central European Standard Time on Apr 09, 2026お知らせ • Sep 12Robertet SA to Report First Half, 2025 Final Results on Sep 18, 2025Robertet SA announced that they will report first half, 2025 final results on Sep 18, 2025お知らせ • Jul 25Robertet SA to Report First Half, 2025 Results on Sep 11, 2025Robertet SA announced that they will report first half, 2025 results on Sep 11, 2025お知らせ • Apr 29Robertet SA, Annual General Meeting, Jun 04, 2025Robertet SA, Annual General Meeting, Jun 04, 2025. Location: 48 avenue jean maubert, grasse Franceお知らせ • Nov 06Robertet SA (ENXTPA:RBT) agreed to acquire Phasex Corporation.Robertet SA (ENXTPA:RBT) agreed to acquire Phasex Corporation on November 4, 2024.Reported Earnings • Sep 26First half 2024 earnings released: EPS: €24.71 (vs €19.14 in 1H 2023)First half 2024 results: EPS: €24.71 (up from €19.14 in 1H 2023). Revenue: €414.6m (up 10% from 1H 2023). Net income: €51.7m (up 29% from 1H 2023). Profit margin: 13% (up from 11% in 1H 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 5.6% p.a. on average during the next 3 years, compared to a 4.3% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has fallen by 1% per year, which means it is significantly lagging earnings.Board Change • Jun 06High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Independent Director Lucie Maurel-Aubert was the last director to join the board, commencing their role in 2023. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.Reported Earnings • Apr 21Full year 2023 earnings released: EPS: €35.71 (vs €32.85 in FY 2022)Full year 2023 results: EPS: €35.71. Revenue: €735.6m (up 4.6% from FY 2022). Net income: €74.6m (down 1.9% from FY 2022). Profit margin: 10% (in line with FY 2022). Revenue is forecast to grow 5.3% p.a. on average during the next 3 years, compared to a 3.7% growth forecast for the Chemicals industry in Germany.New Risk • Apr 16New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. This is currently the only risk that has been identified for the company.お知らせ • Apr 12+ 2 more updatesRobertet SA to Report First Half, 2024 Results on Sep 23, 2024Robertet SA announced that they will report first half, 2024 results on Sep 23, 2024Reported Earnings • Oct 05First half 2023 earnings released: EPS: €19.13 (vs €19.49 in 1H 2022)First half 2023 results: EPS: €19.13 (down from €19.49 in 1H 2022). Revenue: €376.4m (up 4.9% from 1H 2022). Net income: €39.9m (down 11% from 1H 2022). Profit margin: 11% (down from 13% in 1H 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 4.6% p.a. on average during the next 3 years, compared to a 2.0% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 15% per year but the company’s share price has fallen by 6% per year, which means it is significantly lagging earnings.Upcoming Dividend • Jun 22Upcoming dividend of €8.50 per share at 1.0% yieldEligible shareholders must have bought the stock before 29 June 2023. Payment date: 03 July 2023. Payout ratio is a comfortable 26% and the cash payout ratio is 77%. Trailing yield: 1.0%. Lower than top quartile of German dividend payers (4.7%). Lower than average of industry peers (6.3%).Buying Opportunity • Apr 27Now 21% undervalued after recent price dropOver the last 90 days, the stock is down 1.0%. The fair value is estimated to be €1,068, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 5.8% over the last 3 years. Earnings per share has grown by 14%. Revenue is forecast to grow by 12% in 2 years. Earnings is forecast to grow by 6.0% in the next 2 years.Board Change • Nov 16Less than half of directors are independentThere is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 8 experienced directors. No highly experienced directors. 3 independent directors (6 non-independent directors). Director Elie Vannier was the last director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.Reported Earnings • May 01Full year 2021 earnings releasedFull year 2021 results: Revenue: €608.8m (up 13% from FY 2020). Net income: €71.7m (up 42% from FY 2020). Profit margin: 12% (up from 9.4% in FY 2020). The increase in margin was driven by higher revenue. Over the next year, revenue is forecast to grow 11%, compared to a 11% growth forecast for the industry in Germany.Board Change • Apr 27Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 9 experienced directors. No highly experienced directors. 3 independent directors (6 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.Reported Earnings • Oct 01First half 2021 earnings released: EPS €16.47 (vs €13.03 in 1H 2020)The company reported a strong first half result with improved earnings, revenues and profit margins. First half 2021 results: Revenue: €297.6m (up 6.2% from 1H 2020). Net income: €38.1m (up 27% from 1H 2020). Profit margin: 13% (up from 11% in 1H 2020). The increase in margin was driven by higher revenue.Reported Earnings • May 05Full year 2020 earnings released: EPS €21.88 (vs €22.96 in FY 2019)The company reported a poor full year result with weaker earnings and revenues, although profit margins were flat. Full year 2020 results: Revenue: €538.3m (down 2.9% from FY 2019). Net income: €50.6m (down 4.7% from FY 2019). Profit margin: 9.4% (in line with FY 2019).Is New 90 Day High Low • Jan 28New 90-day high: €949The company is up 6.0% from its price of €894 on 30 October 2020. The German market is up 19% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 28% over the same period.Is New 90 Day High Low • Dec 05New 90-day low: €873The company is down 9.0% from its price of €962 on 04 September 2020. The German market is up 5.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 13% over the same period.Is New 90 Day High Low • Oct 13New 90-day high: €1,038The company is up 9.0% from its price of €952 on 15 July 2020. The German market is up 4.0% over the last 90 days, indicating the company outperformed over that time. However, its price trend is similar to the Chemicals industry, which is also up 9.0% over the same period.Reported Earnings • Oct 02First half earnings releasedOver the last 12 months the company has reported total profits of €53.7m, largely unchanged from the prior year. Total revenue was €547.4m over the last 12 months, up 1.0% from the prior year.財務状況分析短期負債: 0R7の 短期資産 ( €603.9M ) が 短期負債 ( €195.7M ) を超えています。長期負債: 0R7の短期資産 ( €603.9M ) が 長期負債 ( €203.8M ) を上回っています。デット・ツー・エクイティの歴史と分析負債レベル: 0R7の 純負債対資本比率 ( 7.4% ) は 満足できる 水準であると考えられます。負債の削減: 0R7の負債対資本比率は、過去 5 年間で15.6%から37.4%に増加しました。債務返済能力: 0R7の負債は 営業キャッシュフロー によって 十分にカバー されています ( 49.3% )。インタレストカバレッジ: 0R7の負債に対する 利息支払い は EBIT ( 40 x coverage) によって 十分にカバーされています。貸借対照表健全な企業の発掘7D1Y7D1Y7D1YMaterials 業界の健全な企業。View Dividend企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/21 21:59終値2026/05/21 00:00収益2025/12/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Robertet SA 8 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。15 アナリスト機関Fraser DonlonBerenbergMarie-Line FortBernsteinNicola TangBNP Paribas12 その他のアナリストを表示
Declared Dividend • May 21Dividend increased to €12.00Dividend of €12.00 is 20% higher than last year. Ex-date: 29th June 2026 Payment date: 1st July 2026 Dividend yield will be 1.5%, which is lower than the industry average of 6.1%. Sustainability & Growth Dividend is well covered by both earnings (25% earnings payout ratio) and cash flows (40% cash payout ratio). The dividend has increased by an average of 12% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. EPS is expected to grow by 24% over the next 3 years, which should provide support to the dividend and adequate earnings cover.
Board Change • May 21Less than half of directors are independentFollowing the recent departure of a director, there are only 5 independent directors on the board. The company's board is composed of: 5 independent directors. 6 non-independent directors. Independent Director Guy Talbourdet was the last independent director to join the board, commencing their role in 2025. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
お知らせ • Apr 28Robertet SA, Annual General Meeting, Jun 03, 2026Robertet SA, Annual General Meeting, Jun 03, 2026. Location: 48 avenue jean maubert, grasse France
お知らせ • Apr 11Robertet SA Proposes Dividend for the Year 2025Robertet SA announced the Annual General Meeting will be held on June 3, 2026 and the shareholders will be invited to approve a dividend payment of €12 per share, up 20% on the previous year owing to Robertet's strong results in 2025.
お知らせ • Feb 12Robertet SA to Report First Half, 2026 Final Results on Sep 21, 2026Robertet SA announced that they will report first half, 2026 final results on Sep 21, 2026
お知らせ • Jan 02+ 2 more updatesRobertet SA to Report Fiscal Year 2025 Results on Apr 09, 2026Robertet SA announced that they will report fiscal year 2025 results at 9:00 AM, Central European Standard Time on Apr 09, 2026
お知らせ • Sep 12Robertet SA to Report First Half, 2025 Final Results on Sep 18, 2025Robertet SA announced that they will report first half, 2025 final results on Sep 18, 2025
お知らせ • Jul 25Robertet SA to Report First Half, 2025 Results on Sep 11, 2025Robertet SA announced that they will report first half, 2025 results on Sep 11, 2025
お知らせ • Apr 29Robertet SA, Annual General Meeting, Jun 04, 2025Robertet SA, Annual General Meeting, Jun 04, 2025. Location: 48 avenue jean maubert, grasse France
お知らせ • Nov 06Robertet SA (ENXTPA:RBT) agreed to acquire Phasex Corporation.Robertet SA (ENXTPA:RBT) agreed to acquire Phasex Corporation on November 4, 2024.
Reported Earnings • Sep 26First half 2024 earnings released: EPS: €24.71 (vs €19.14 in 1H 2023)First half 2024 results: EPS: €24.71 (up from €19.14 in 1H 2023). Revenue: €414.6m (up 10% from 1H 2023). Net income: €51.7m (up 29% from 1H 2023). Profit margin: 13% (up from 11% in 1H 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 5.6% p.a. on average during the next 3 years, compared to a 4.3% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has fallen by 1% per year, which means it is significantly lagging earnings.
Board Change • Jun 06High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Independent Director Lucie Maurel-Aubert was the last director to join the board, commencing their role in 2023. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.
Reported Earnings • Apr 21Full year 2023 earnings released: EPS: €35.71 (vs €32.85 in FY 2022)Full year 2023 results: EPS: €35.71. Revenue: €735.6m (up 4.6% from FY 2022). Net income: €74.6m (down 1.9% from FY 2022). Profit margin: 10% (in line with FY 2022). Revenue is forecast to grow 5.3% p.a. on average during the next 3 years, compared to a 3.7% growth forecast for the Chemicals industry in Germany.
New Risk • Apr 16New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. This is currently the only risk that has been identified for the company.
お知らせ • Apr 12+ 2 more updatesRobertet SA to Report First Half, 2024 Results on Sep 23, 2024Robertet SA announced that they will report first half, 2024 results on Sep 23, 2024
Reported Earnings • Oct 05First half 2023 earnings released: EPS: €19.13 (vs €19.49 in 1H 2022)First half 2023 results: EPS: €19.13 (down from €19.49 in 1H 2022). Revenue: €376.4m (up 4.9% from 1H 2022). Net income: €39.9m (down 11% from 1H 2022). Profit margin: 11% (down from 13% in 1H 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 4.6% p.a. on average during the next 3 years, compared to a 2.0% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 15% per year but the company’s share price has fallen by 6% per year, which means it is significantly lagging earnings.
Upcoming Dividend • Jun 22Upcoming dividend of €8.50 per share at 1.0% yieldEligible shareholders must have bought the stock before 29 June 2023. Payment date: 03 July 2023. Payout ratio is a comfortable 26% and the cash payout ratio is 77%. Trailing yield: 1.0%. Lower than top quartile of German dividend payers (4.7%). Lower than average of industry peers (6.3%).
Buying Opportunity • Apr 27Now 21% undervalued after recent price dropOver the last 90 days, the stock is down 1.0%. The fair value is estimated to be €1,068, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 5.8% over the last 3 years. Earnings per share has grown by 14%. Revenue is forecast to grow by 12% in 2 years. Earnings is forecast to grow by 6.0% in the next 2 years.
Board Change • Nov 16Less than half of directors are independentThere is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 8 experienced directors. No highly experienced directors. 3 independent directors (6 non-independent directors). Director Elie Vannier was the last director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
Reported Earnings • May 01Full year 2021 earnings releasedFull year 2021 results: Revenue: €608.8m (up 13% from FY 2020). Net income: €71.7m (up 42% from FY 2020). Profit margin: 12% (up from 9.4% in FY 2020). The increase in margin was driven by higher revenue. Over the next year, revenue is forecast to grow 11%, compared to a 11% growth forecast for the industry in Germany.
Board Change • Apr 27Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 9 experienced directors. No highly experienced directors. 3 independent directors (6 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
Reported Earnings • Oct 01First half 2021 earnings released: EPS €16.47 (vs €13.03 in 1H 2020)The company reported a strong first half result with improved earnings, revenues and profit margins. First half 2021 results: Revenue: €297.6m (up 6.2% from 1H 2020). Net income: €38.1m (up 27% from 1H 2020). Profit margin: 13% (up from 11% in 1H 2020). The increase in margin was driven by higher revenue.
Reported Earnings • May 05Full year 2020 earnings released: EPS €21.88 (vs €22.96 in FY 2019)The company reported a poor full year result with weaker earnings and revenues, although profit margins were flat. Full year 2020 results: Revenue: €538.3m (down 2.9% from FY 2019). Net income: €50.6m (down 4.7% from FY 2019). Profit margin: 9.4% (in line with FY 2019).
Is New 90 Day High Low • Jan 28New 90-day high: €949The company is up 6.0% from its price of €894 on 30 October 2020. The German market is up 19% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 28% over the same period.
Is New 90 Day High Low • Dec 05New 90-day low: €873The company is down 9.0% from its price of €962 on 04 September 2020. The German market is up 5.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 13% over the same period.
Is New 90 Day High Low • Oct 13New 90-day high: €1,038The company is up 9.0% from its price of €952 on 15 July 2020. The German market is up 4.0% over the last 90 days, indicating the company outperformed over that time. However, its price trend is similar to the Chemicals industry, which is also up 9.0% over the same period.
Reported Earnings • Oct 02First half earnings releasedOver the last 12 months the company has reported total profits of €53.7m, largely unchanged from the prior year. Total revenue was €547.4m over the last 12 months, up 1.0% from the prior year.